Tenax Therapeutics (NASDAQ:TENX) CEO Christopher Thomas Giordano Buys 6,000 Shares
MarketBeat
Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) CEO Christopher Giordano purchased 6,000 shares of the company's stock in a transaction on Friday, September 11th. The stock was acquired at an average price of $1.88 per share, with a total value of $11,280.00. Following the completion of the purchase, the chief executive officer directly owned 17,324 shares in the company, valued at $32,569.12. This trade represents a 52.98% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
NASDAQ:TENX